참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Clarithromycin | HCID 84029 | — |
| 용매 | Formic Acid | HCID 284 | — |
| 생성물 | Clarithromycin formate | HCID 86758498 | — |
반응 단계
Specifically, clarithromycin is dissolved in an organic solvent at a temperature ranging from room temperature to the boiling point of the solvent for a period sufficient to make a solution or suspension. Then, formic acid, neat or dissolved in an organic solvent, is added to the solution or suspension in an amount ranging from 1 to 5 moles based on 1 mole of clarithromycin. The mixture may then be optionally kept at a temperature in the range of room temperature to the boiling point of the solvent for 10 minutes to 1 hour. The resulting mixture is cooled to a temperature in the range of −20° C. to room temperature for a period sufficient to precipitate formate crystals of clarithromycin. Finally, the precipitated crystals are filtered and dried in a conventional manner to give crystalline clarithromycin formate.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US06444796B1 |
|---|
| 출처 데이터셋 | uspto-grants-2002_09 |
|---|
| ORD ID | ord-ebf02882d6074b4b95bfd90db55aacd0 |
|---|
| 출처 메모 | uspto-grants-2002_09 |
|---|